ALPHA TRIBE

Shilpa Medicare LimitedUpdates, 22-11-2025: General Updates

22-11-2025 | 11:55 am

Shilpa Medicare's Jadcherla Unit IV USFDA inspection concluded with 8 observations; none were repeats. US sales from this unit are less than 1% of total business for H1 FY26, suggesting minimal immediate revenue risk. The company plans to respond.

No comments yet. Be the first to comment!

All announcements from Shilpa Medicare Limited